TrialThe Journal of clinical investigation2020

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.

Gordon I Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.